TBG Biotechnology Corp. is founded in 2006 with a focus in Immunogenetics and Inheritable Genetic Diseases. TBG has developed IVD products for organ and stem cell transplantation, transfusion safety, adverse drug reaction, autoimmunity, vaccine efficacy, immunotherapy , cellular therapy , fertility and immunodeficiency. Our platforms include PCR, real time PCR, Sanger Sequencing and NGS. For inheritable genetics diseases, TBG has developed products for Hearing loss gene testing, Marfane Disease, Tuberous Sclerosis Complex (TSC), Polycystic Kidney Disease (PKD), Epidermolysis Bullosa (EB), Thalessemia, Fragile X syndrome, and Smooth Muscle Atrophy (SMA). We also offer whole genome, whole exome and RNAseq. Other than reagents, TBG also offer DNA extraction system, automated pipetting system and real time PCR machine.